Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Urinary Bladder Neoplasms 12 Neoplasms 10 Carcinoma, Renal Cell 9 Ovarian Neoplasms 7 Carcinoma, Transitional Cell 7 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Merkel Cell 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1

Interventions

Gemcitabine 30 Cisplatin 20 pembrolizumab 8 Fluorouracil 5 Capecitabine 5 130-nm albumin-bound paclitaxel 5 Taxes 4 Oxaliplatin 4 Albumin-Bound Paclitaxel 4 pemigatinib 3 infigratinib 3 durvalumab 3 atezolizumab 3 Specimen Handling 3 Radiosurgery 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Carboplatin 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 trametinib 2 olaparib 2 ivosidenib 2 derazantinib 2 cobimetinib 2 Trastuzumab 2 Radiotherapy 2 Panitumumab 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡